GlassScriptPhysician profile
Jessica Cunningham
NPI 1144494576
$3,427.86
in general payments reported to CMS, 2019-2025
34 companies · $598 in 2025
The $598 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $280 · 2021: $490 · 2022: $415 · 2023: $490 · 2024: $554 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.40 |
| Education | $283.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.55 | 2019-2025 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $417.96 | 2019-2024 | |
| Astellas Pharma US INC | $405.92 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $327.89 | 2021-2025 | |
| Agile Therapeutics, INC. | $212.27 | 2021-2024 | Twirla |
| Pfizer INC. | $189.58 | 2019-2022 | |
| Organon LLC | $146.43 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $140.34 | 2019-2024 | Slynd, Nuvessa |
| Hologic Sales and Service, LLC | $132.69 | 2019-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Therapeuticsmd, INC. | $106.84 | 2019-2022 | |
| Minerva Surgical, INC | $105.78 | 2023-2025 | |
| Shield Therapeutics INC | $85.58 | 2025 | |
| Medtronic, INC. | $73.56 | 2021-2025 | Truclear |
| Roche Diagnostics Corporation | $73.02 | 2019-2020 | |
| Sage Therapeutics, LLC | $50.60 | 2024-2025 | Zurzuvae |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $50.01 | 2019-2023 | Balcoltra |
| Millicent US INC | $45.62 | 2025 | Femlyv |
| Allergan, INC. | $37.93 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.52 | 2025 | |
| Nestle Healthcare Nutrition INC. | $23.78 | 2022 | |
| Avanos Medical | $23.00 | 2019 | |
| Mission Pharmacal Company | $21.92 | 2020 | |
| Amag Pharmaceuticals, INC. | $21.65 | 2019 | |
| Merck Sharp & Dohme LLC | $21.37 | 2023 | Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $21.31 | 2025 | Qelbree |
| Medicem INC. | $19.84 | 2020 | |
| Duchesnay USA Incorporated | $18.85 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.83 | 2021 | |
| Meditrina | $17.74 | 2023 | |
| Aimmune Therapeutics, INC. | $15.80 | 2025 | Zenpep |
| Alydia Health | $15.65 | 2021 | |
| Scynexis, INC. | $15.39 | 2022 | |
| Covidien LP | $13.33 | 2019 | |
| Ethicon US, LLC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.